Ameriprise’s Faeth Therapeutics FTH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTH
BBA
Ameriprise's FTH Position: Q3 2026 in Review
Ameriprise opened a new position in Faeth Therapeutics (FTH) in Q3 2026: 682,494 shares worth $20.3M. The stake represents ﹤0.01% of the portfolio and ranks #1481 among its holdings.
79 funds tracked by Wall St. Rank hold FTH as of Q3 2026.
- Ameriprise held 682,494 shares of Faeth Therapeutics worth $20.3M as of Q3 2026.
- Faeth Therapeutics was a new Ameriprise position in Q3 2026.
- Faeth Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #1481 holding.
- 79 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2026.
Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.